Despite unprecedented challenges brought by the COVID-19 pandemic, 2020 was a productive and successful year for the cannabis industry. Now, as we enter the new year, let’s take a look at the U.S. states that could go green in 2021.
New York governor Andrew Cuomo has pledged that the state will work to legalise recreational cannabis throughout 2021, announcing a new proposal to create a system to oversee and regulate the drug.
We’ve seen the pandemic reorient how we interact with businesses, each other and the world around us. It’s accelerated many trends in business — from e-commerce to digital payments — by several years in a matter of months.
As the economic cost of coronavirus deepens, questions of how the government plans to pay back the mounting debt continue to be asked.
The US House of Representatives has passed a bill to decriminalise cannabis at the national level for the first time.
The UN Commission on Narcotic Drugs has voted to remove cannabis from a category of the world’s most dangerous drugs.
Back in March, COVID-19 took the world by storm. Since that time, there been a desperate search for anything that can treat, cure, or even prevent this virus. While we still don’t have all the answers, cannabis has surprisingly found a spotlight within this pandemic.
From 1 November this year, a new cannabis exemption card will be available to protect medicinal cannabis patients from arrest and legal prosecution in the UK.
Major developments are happening in the global cannabis industry. Most recently, the European Union legalized a cannabinoid-based medication for patients aged two years and above who suffer from rare types of epilepsy; Lennox-Gastaut syndrome and Dravet syndrome. The name of that medication was Epidiolex – produced by British drug company GW Pharmaceuticals.
A longstanding zero-tolerance cannabis policy could be slowly eroding in the military.